| 注册
首页|期刊导航|世界中医药|芪苈强心胶囊对慢性心力衰竭患者血浆BNP及hs-cTnT的影响

芪苈强心胶囊对慢性心力衰竭患者血浆BNP及hs-cTnT的影响

利玲 戴晓彬

世界中医药2016,Vol.11Issue(7):1247-1250,4.
世界中医药2016,Vol.11Issue(7):1247-1250,4.DOI:10.3969/j.issn.1673-7202.2016.07.024

芪苈强心胶囊对慢性心力衰竭患者血浆BNP及hs-cTnT的影响

The Effect of BNP and hs-cTnT of Qiliqiangxin Capsule on Patients with Chronic Heart

利玲 1戴晓彬2

作者信息

  • 1. 鄂东医疗集团黄石市中心医院药学部,黄石,435000
  • 2. 鄂东医疗集团黄石市中医医院 湖北理工学院附属医院 内科,黄石,435000
  • 折叠

摘要

Abstract

Objective:To investigate the effect of BNP and hs-cTnT of Qiliqiangxin capsule on patients with chronic heart. Methods:Select March 2015-November 2015 our hospital for 60 patients with chronic heart failure according to the random number table method were divided into control group and observation group. Observation group had 30 patients,in the conventional manner using the premise plus service Qiliqiangxin capsule treatment;control group of 30 patients were treated in a conventional manner. Analyzing of two groups of patients before and after treatment of levels of plasma BNP,hs-cTnT,hs-CRP,IL-1,IL-6,TNF-α,6-minute walk distance and cardiac ultrasound indicators and related clinical total efficiency. Results:Two groups of patients compared plasma BNP and hs-cTnT levels before treatment were decreased,but the observation group was gooder than the control group,being statistically significant (P<0. 05); compared with the two groups of patients before treatment,receiving after treat-ment of 6-minute walk tested distance have increased,but the observation group was significantly higher and the relevant parameters were significantly better than the ultrasound than the control group being statistically significant(P<0. 05);two groups of patients before treatment phase than,after receiving treatment hs-CRP,IL-1,IL-6 and TNF-α levels were decreased,but the observation group was significantly lower than the control group,being statistically significant (P<0. 05);there is always a group of patients observed efficiency ( 93. 33%) was significantly higher ( 76. 67%) , comparing two sets of data was statistically significant ( P<0. 05). Conclusion:Qiliqiangxin capsule can effectively improve patients′ heart function,enabling the plasma BNP and hs-cTnT levels were significantly reduced,which helps to treat chronic heart failure,worthy of promotion and application in clinical practice.

关键词

慢性心力衰竭/芪苈强心胶囊/血浆BNP/hs-cTnT

Key words

Chronic heart failure/Qiliqiangxin Capsule/BNP/Hs-cTnT

分类

医药卫生

引用本文复制引用

利玲,戴晓彬..芪苈强心胶囊对慢性心力衰竭患者血浆BNP及hs-cTnT的影响[J].世界中医药,2016,11(7):1247-1250,4.

基金项目

黄石市科技计划项目(编号:2012A070-6) (编号:2012A070-6)

世界中医药

OACHSSCDCSTPCD

1673-7202

访问量0
|
下载量0
段落导航相关论文